Tanya Siddiqi Selected Research

Tanya Siddiqi Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 01/2014
19	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 03/2015
14	Lymphoma (Lymphomas) 01/2024 - 05/2014
9	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2017
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2021 - 03/2015
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2024 - 10/2020
5	Residual Neoplasm 01/2024 - 01/2018
5	Disease Progression 01/2023 - 03/2015
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 01/2017
4	Neutropenia 11/2023 - 05/2014
4	Hodgkin Disease (Hodgkin's Disease) 10/2022 - 01/2014
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 03/2015
3	Atrial Fibrillation 11/2023 - 10/2020
3	Diarrhea 11/2023 - 12/2015
3	Leukemia 01/2022 - 12/2017
3	Hemorrhage 12/2020 - 12/2015
2	Spasm (Spasms) 11/2023 - 10/2020
2	Hypertension (High Blood Pressure) 11/2023 - 12/2020
2	Pneumonia (Pneumonitis) 11/2023 - 10/2020
2	Tumor Lysis Syndrome 01/2022 - 12/2021
2	Cytokine Release Syndrome 01/2021 - 01/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 12/2017
2	Pathologic Complete Response 12/2015 - 10/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024
1	COVID-19 12/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Musculoskeletal Pain 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Myalgia 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Infections 10/2020
1	Edema (Dropsy) 10/2020
1	Contusions 10/2020
1	Multiple Myeloma 10/2020
1	Hairy Cell Leukemia 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018

Drug/Important Bio-Agent (IBA)

15	ibrutinibIBA 02/2024 - 12/2015
8	axicabtagene ciloleucelIBA 04/2024 - 01/2017
8	Chimeric Antigen ReceptorsIBA 04/2024 - 12/2017
7	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 10/2016
7	venetoclaxIBA 01/2024 - 12/2021
6	Brentuximab VedotinIBA 01/2019 - 01/2014
5	Rituximab (Mabthera)FDA Link 12/2022 - 10/2008
4	zanubrutinibIBA 02/2024 - 10/2020
4	Monoclonal AntibodiesIBA 01/2021 - 01/2014
3	Messenger RNA (mRNA)IBA 12/2023 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 12/2017
3	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 01/2014
2	fludarabineIBA 01/2022 - 12/2017
2	AntigensIBA 01/2021 - 01/2019
2	Vorinostat FDA Link 01/2020 - 03/2015
2	umbralisibIBA 11/2019 - 02/2019
2	ublituximabIBA 11/2019 - 02/2019
2	AnticoagulantsIBA 11/2018 - 09/2015
2	Bortezomib (Velcade)FDA Link 01/2018 - 10/2008
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2024
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Bispecific AntibodiesIBA 01/2024
1	COVID-19 VaccinesIBA 12/2023
1	mRNA VaccinesIBA 12/2023
1	VaccinesIBA 12/2023
1	pevonedistatIBA 01/2023
1	RNA Splicing FactorsIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2023
1	EnzymesIBA 01/2023
1	InterferonsIBA 01/2023
1	ChemokinesIBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	polatuzumab vedotinIBA 12/2022
1	Vincristine (Oncovin)FDA LinkGeneric 12/2022
1	Prednisone (Sone)FDA LinkGeneric 12/2022
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Programmed Cell Death 1 ReceptorIBA 12/2022
1	avelumabIBA 10/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	BI 836826IBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	Ritonavir (Norvir)FDA Link 10/2020
1	Aurora Kinase AIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	MLN 8237IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	AnthracyclinesIBA 01/2019
1	immunotoxin HA22IBA 01/2018

Therapy/Procedure

27	Therapeutics 04/2024 - 03/2015
6	Drug Therapy (Chemotherapy) 10/2021 - 01/2014
6	Stem Cell Transplantation 01/2019 - 01/2014
3	Cell Transplantation 01/2022 - 11/2014
2	Immunotherapy 01/2024 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 01/2014
1	Intravenous Infusions 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022